celcuity logo
X
  • Home
  • Platform
    • Pipeline
    • CELsignia Overview
    • Gedatolisib
    • Clinical Trials
  • About
    • About Celcuity
    • Our Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Preclinical Studies
    • Publications
    • Biopharma collaborations
  • News
  • Investors
    • Investors Overview
    • Corporate Governance
    • Press Releases
    • SEC Filings
    • Events & Webcasts
    • FAQs
  • Contact

Events & Webcasts

© 2021 Celcuity, Inc. All rights reserved.
Licensure: CLIA ID #: 24D2098245 / CAP #: 9387225